Properties of blood-contacting surfaces of clinically implanted cardiac assist devices: Gene expression, matrix composition, and ultrastructural characterization of cellular linings

1995 ◽  
Vol 57 (3) ◽  
pp. 557-573 ◽  
Author(s):  
Michael J. Menconi ◽  
Shirwin Pockwinse ◽  
Thomas A. Owen ◽  
Kurt A. Dasse ◽  
Gary S. Stein ◽  
...  
1988 ◽  
Vol 6 (3) ◽  
pp. 449-459 ◽  
Author(s):  
John A. Elefteriades

2008 ◽  
Vol 56 (S 1) ◽  
Author(s):  
M Petersen ◽  
N Guldner ◽  
M Großherr ◽  
HH Sievers

1997 ◽  
Vol 30 (3) ◽  
pp. 1815-1824 ◽  
Author(s):  
Roland Somogyi ◽  
Stefanie Fuhrman ◽  
Manor Askenazi ◽  
Andy Wuensche

2014 ◽  
Vol 2014 ◽  
pp. 1-12 ◽  
Author(s):  
Sayed Nour ◽  
Jia Liu ◽  
Gang Dai ◽  
Daniel Carbognani ◽  
Daya Yang ◽  
...  

Cardiac assist devices (CAD) cause endothelial dysfunction with considerable morbidity. Employment of pulsatile CAD remains controversial due to inadequate perfusion curves and costs. Alternatively, we are proposing a new concept of pulsatile CAD based on a fundamental revision of the entire circulatory system in correspondence with the physiopathology and law of physics. It concerns a double lumen disposable tube device that could be adapted to conventional cardiopulmonary bypass (CPB) and/or CAD, for inducing a homogenous, downstream pulsatile perfusion mode with lower energy losses. In this study, the device’s prototypes were tested in a simulated conventional pediatric CPB circuit for energy losses and as a left ventricular assist device (LVAD) in ischemic piglets model for endothelial shear stress (ESS) evaluations. In conclusion and according to the study results the pulsatile tube was successfully capable of transforming a conventional CPB and/or CAD steady flow into a pulsatile perfusion mode, with nearly physiologic pulse pressure and lower energy losses. This represents a cost-effective promising method with low mortality and morbidity, especially in fragile cardiac patients.


2021 ◽  
Author(s):  
Hossein Fazeli Khalili ◽  
Jens Kirchner ◽  
Max Bartunik ◽  
Siegfried Werner ◽  
Nina Ebel ◽  
...  

This manuscript was submitted at 29.12.2020 to the IEEE Transactions on Biomedical Engineering.


2021 ◽  
Author(s):  
Hossein Fazeli Khalili ◽  
Jens Kirchner ◽  
Max Bartunik ◽  
Siegfried Werner ◽  
Nina Ebel ◽  
...  

This manuscript was submitted at 29.12.2020 to the IEEE Transactions on Biomedical Engineering.


2015 ◽  
Vol 10 (1) ◽  
pp. 39 ◽  
Author(s):  
Dagmar M Ouweneel ◽  
Bimmer E Claessen ◽  
Krischan D Sjauw ◽  
José PS Henriques ◽  
◽  
...  

The experience and usage of percutaneous cardiac assist devices in cardiogenic shock as well as high-risk percutaneous coronary intervention have increased over the years. Nonetheless, there is still little evidence of clinical benefit of these devices other than immediate haemodynamic improvement. Despite the fact that these devices are used to treat a rather complex patient population, clinical testing remains important in order to evaluate their true impact on clinical outcome before being adopted into clinical practice. Therefore, this review shows an overview of the current experience and evidence of the available percutaneous cardiac assist devices.


Sign in / Sign up

Export Citation Format

Share Document